Onesource Specialty Pharma Ltd
ONESOURCEBSE 544292PharmaceuticalsMkt cap ₹17,313 Cr
Whole group, including subsidiaries — the figures companies headline.
Revenue · Q1 FY27
₹449 Cr
YoY +37.2%QoQ +4.9%
Net profit · Q1 FY27
₹25.00 Cr
YoY —QoQ +443.5%
Net margin · Q1 FY27
5.6%
+5.6 pts vs Q1 FY26
Net profit · FY26
₹-73.80 Cr
YoY —
Quarterly results
| ₹ Cr | Q1 FY27 Apr–Jun 2026 | Q4 FY26 Jan–Mar 2026 | Q3 FY26 Oct–Dec 2025 | Q2 FY26 Jul–Sep 2025 | Q1 FY26 Apr–Jun 2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | 449 | 428 | 290 | 376 | 327 | +37.2% |
| Other income | 3.80 | 2.09 | 4.63 | 3.04 | 5.27 | -27.9% |
| Total income | 453 | 430 | 295 | 379 | 333 | +36.2% |
| Profit before tax | 20.29 | 0.00 | 0.00 | 5.74 | 0.00 | — |
| Tax | -4.70 | -4.89 | -4.31 | -4.74 | -4.21 | — |
| Net profit | 25.00 | 4.60 | -88.70 | 10.49 | -0.19 | — |
| Net margin | 5.6% | 1.1% | -30.6% | 2.8% | -0.1% |
Annual results
| ₹ Cr | FY26 Apr 2025–Mar 2026 | FY25 Apr 2024–Mar 2025 | YoY |
|---|---|---|---|
| Revenue | 1,422 | 1,445 | -1.6% |
| Other income | 15.02 | 17.47 | -14.0% |
| Total income | 1,437 | 1,462 | -1.8% |
| Profit before tax | 0.00 | 0.00 | — |
| Tax | -18.16 | -49.79 | — |
| Net profit | -73.80 | -17.97 | — |
| Net margin | -5.2% | -1.2% |
BIC's take
We haven't covered Onesource Specialty Pharma Ltd yet. Browse our sector reports →
Source: BSE filings · Data as of 2 Oct 2026, 6:38 pm IST· ₹ crore unless stated. Covers BSE 500 companies only. Consolidated figures include subsidiaries; standalone is the parent company alone. Growth is shown only against a positive base. Not investment advice — check the company's full filing before acting.